Guidance on communication regarding medtech regulatory changes issued

03/31/2014 | Clinica (subscription required)

The FDA's device center has issued guidelines on how it intends to notify companies of immediate changes in medical device regulatory expectations that could affect pending applications. One of the goals of the new process is to allow manufacturers to more quickly learn of modifications rather than wait until a regulatory decision is made.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC